The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TCR clonality and Treg frequency as predictors of outcome in stage III NSCLC treated with durvalumab.
 
Sally CM Lau
No Relationships to Disclose
 
Shirin Soleimani
No Relationships to Disclose
 
Stephanie WY Wong
No Relationships to Disclose
 
Stephanie Pedersen
No Relationships to Disclose
 
Ben X Wang
No Relationships to Disclose
 
Arielle Elkrief
No Relationships to Disclose
 
Devalben Patel
No Relationships to Disclose
 
Aline Fusco Fares
No Relationships to Disclose
 
Kevin Jao
Honoraria - Pfizer
Consulting or Advisory Role - Boehringer Ingelheim; Merck; pfizer
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst)
 
Nathalie Daaboul
No Relationships to Disclose
 
Taiki Hakozaki
No Relationships to Disclose
 
Penelope Ann Bradbury
Honoraria - Abbvie; Lilly; Merck
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim
 
Geoffrey Liu
Honoraria - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Merck; novartis; pfizer; Roche Canada; Takeda
Consulting or Advisory Role - AstraZeneca/MedImmune; novartis; pfizer; Roche Canada; takeda
Speakers' Bureau - AstraZeneca; Takeda
Research Funding - AstraZeneca/MedImmune (Inst); roche (Inst); Takeda
 
Natasha B. Leighl
Consulting or Advisory Role - Xcovery
Research Funding - Array BioPharma (Inst); Guardant Health (Inst); Novartis (Inst); Roche Canada (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Nektar; Roche
 
Ming-Sound Tsao
No Relationships to Disclose
 
Pamela S Ohashi
Consulting or Advisory Role - Providence Therapeutics; Tessa Therapeutics
 
Trevor John Pugh
Honoraria - Chrysalis Biomedical Advisors; Merck; Prosigna
Consulting or Advisory Role - DynaCare
Research Funding - Boehringer Ingelheim (Inst)
Patents, Royalties, Other Intellectual Property - Combined hybrid-capture DNA sequencing for disease detection; Hybrid-capture sequencing for dete rmining immune cell clonality
 
Bertrand Routy
No Relationships to Disclose
 
Frances A. Shepherd
Stock and Other Ownership Interests - AstraZeneca; Lilly
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Merck Serono; Merck Sharp & Dohme; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck Serono
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merrimack (Inst); Pfizer (Inst); Roche Canada (Inst)
 
Adrian G. Sacher
Honoraria - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Genentech/Roche; KisoJi Biotechnology; Merck; Pfizer; Tesaro
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Genentech/Roche; KisoJi Biotechnology; Merck; Pfizer
Research Funding - AstraZeneca; Genentech/Roche
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche; GlaxoSmithKline; Gritstone Bio; Pfizer